Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedema Attack”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Not applicableStudy completedNCT01059526
What this trial is testing

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 81
Testing effectiveness (Phase 2)Study completedNCT01756157
What this trial is testing

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

Who this might be right for
Hereditary Angioedema (HAE)
Shire 47
Testing effectiveness (Phase 2)Study completedNCT04618211
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 74
Not applicableStudy completedNCT01541423
What this trial is testing

A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 83
Large-scale testing (Phase 3)Enrolling By InvitationNCT06679881
What this trial is testing

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 170
Large-scale testing (Phase 3)WithdrawnNCT01253382
What this trial is testing

Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire
Large-scale testing (Phase 3)Study completedNCT04654351
What this trial is testing

Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 2
Large-scale testing (Phase 3)Study completedNCT00292981
What this trial is testing

C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)

Who this might be right for
Hereditary Angioedema
CSL Behring 57
Large-scale testing (Phase 3)Study completedNCT02741596
What this trial is testing

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 212
Testing effectiveness (Phase 2)Study completedNCT00261053
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Genetic Disorders
Pharming Technologies B.V. 14
Large-scale testing (Phase 3)Study completedNCT00456508
What this trial is testing

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 147
Large-scale testing (Phase 3)Active Not RecruitingNCT06669754
What this trial is testing

Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 81
Testing effectiveness (Phase 2)UnknownNCT04489160
What this trial is testing

Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury

Who this might be right for
Traumatic Brain InjuryTrauma, Head
Leiden University Medical Center 106
Testing effectiveness (Phase 2)Study completedNCT01984788
What this trial is testing

Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT00262301
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaAngioneurotic EdemaGenetic Disorders
Pharming Technologies B.V. 75
Testing effectiveness (Phase 2)Study completedNCT02247739
What this trial is testing

HAE Prophylaxis Study With Recombinant Human C1 Inhibitor

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 32
Large-scale testing (Phase 3)Looking for participantsNCT06361537
What this trial is testing

Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

Who this might be right for
Acute Hereditary Angio Edema
Octapharma 124
Not applicableApproved For MarketingNCT04428632
What this trial is testing

Oral Berotralstat Expanded Access Program

Who this might be right for
Hereditary AngioedemaHAEProphylaxis
BioCryst Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT05259917
What this trial is testing

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 136
Post-approval studies (Phase 4)Study completedNCT01467947
What this trial is testing

Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 46
Next Page